• 1. Alternative donor substrates for inverting and retaining glycosyltransferases?
  Luke L. Lairson,Warren W. Wakarchuk Chem. Commun., 2007, 365-367
• 2. Alt-proteins: A promising future
• 3. An interplay between electronic and structural effects on the photoluminescence decay mechanisms in LaPO4·nH2O:Tb3+ and LaPO4:Tb3+ single-crystal nanorods?
  M. T. Colomer,S. Díaz-Moreno,A. Tamayo,A. L. Ortiz J. Mater. Chem. C, 2018,6, 12643-12651
• 4. An arsenic trioxide nanoparticle prodrug (ATONP) potentiates a therapeutic effect on an aggressive hepatocellular carcinoma model via enhancement of intratumoral arsenic accumulation and disturbance of the tumor microenvironment?
  Xin Fu,Qing-rong Liang,Rong-guang Luo,Yan-shu Li,Xiao-ping Xiao,Lu-lu Yu,Wen-zhe Shan,Guang-qin Fan J. Mater. Chem. B, 2019,7, 3088-3099
• 5. An approach towards the synthesis of novel fused nitrogen tricyclic heterocyclic scaffolds via GBB reaction?
  Sandip Gangadhar Balwe,Yeon Tae Jeong Org. Biomol. Chem., 2018,16, 1287-1296

• Solvents and Organic Chemicals Organic Compounds Lipids and lipid-like molecules Fatty Acyls Fatty acid esters

Ethyl 3-bromo-2-oxopentanoate (CAS No. 113264-43-0): A Versatile Intermediate in Modern Chemical Synthesis

Ethyl 3-bromo-2-oxopentanoate, identified by its CAS number 113264-43-0, is a significant compound in the realm of organic synthesis and pharmaceutical research. This ester derivative features a unique structural framework that makes it a valuable intermediate in the preparation of more complex molecules, particularly in the development of novel therapeutic agents and fine chemicals. The presence of both a bromine substituent and a beta-keto ester moiety endows this compound with distinct reactivity patterns, facilitating diverse synthetic transformations.

The utility of Ethyl 3-bromo-2-oxopentanoate stems from its ability to participate in various chemical reactions, including nucleophilic substitutions, condensations, and cyclizations. These reactions are pivotal in constructing intricate molecular architectures essential for drug discovery and material science applications. Recent advancements in synthetic methodologies have highlighted its role in the preparation of heterocyclic compounds, which are widely explored for their pharmacological properties.

In the context of pharmaceutical research, Ethyl 3-bromo-2-oxopentanoate has been employed in the synthesis of bioactive molecules targeting various diseases. For instance, its structural motif is reminiscent of certain natural products known for their antimicrobial and anti-inflammatory effects. Researchers have leveraged its reactivity to develop derivatives with enhanced potency and selectivity. The bromine atom, in particular, serves as a versatile handle for further functionalization, allowing chemists to introduce additional substituents or modify existing ones through cross-coupling reactions.

The compound's significance is further underscored by its application in the synthesis of peptidomimetics and protease inhibitors. These therapeutic agents are critical in treating conditions such as cancer, infectious diseases, and metabolic disorders. By serving as a building block, Ethyl 3-bromo-2-oxopentanoate enables the construction of peptidomimetic cores with tailored biological activities. The beta-keto ester functionality also allows for enantioselective transformations, which are crucial for developing chiral drugs with improved pharmacokinetic profiles.

From an industrial perspective, the demand for high-quality intermediates like Ethyl 3-bromo-2-oxopentanoate continues to grow alongside advancements in drug development technologies. Its synthesis typically involves well-established organic reactions such as bromination of appropriate precursors followed by esterification. These processes highlight the compound's accessibility while maintaining high purity standards essential for pharmaceutical applications. Manufacturers have optimized these synthetic routes to ensure scalability and cost-effectiveness without compromising on yield or quality.

The role of computational chemistry has also emerged as a powerful tool in understanding and optimizing the reactivity of Ethyl 3-bromo-2-oxopentanoate. Molecular modeling studies have provided insights into how different substituents influence its interactions with biological targets. This knowledge has guided the design of novel derivatives with improved binding affinities and reduced side effects. Such computational approaches are increasingly integrated into drug discovery pipelines, streamlining the identification of promising candidates for further development.

Future research directions may explore novel synthetic strategies to expand the chemical space accessible through derivatives of Ethyl 3-bromo-2-oxopentanoate. For example, catalytic asymmetric methods could be employed to enhance enantioselectivity during its synthesis or subsequent transformations. Additionally, green chemistry principles may be applied to develop more sustainable production processes that minimize waste and energy consumption. These efforts align with global initiatives to promote environmentally responsible chemical manufacturing.

The versatility of Ethyl 3-bromo-2-oxopentanoate extends beyond pharmaceuticals into other areas such as agrochemicals and specialty materials. Its structural features make it suitable for synthesizing compounds with specific physical or biological properties required in these industries. As research progresses, new applications are likely to emerge, further solidifying its position as a cornerstone intermediate in modern chemical synthesis.

In conclusion, Ethyl 3-bromo-2-oxopentanoate (CAS No. 113264-43-0) represents a compound of considerable interest due to its multifaceted utility in synthetic chemistry and drug development. Its unique structural attributes enable diverse transformations that are critical for constructing complex molecules with potential therapeutic benefits. As advancements continue to unfold across disciplines like organic synthesis, computational chemistry, and green chemistry, this intermediate will undoubtedly remain at the forefront of innovation-driven research efforts.

• 59742-68-6(Heptanedioic acid, 3-bromo-4-oxo-, diethyl ester)
• 54260-84-3(Ethyl 3-bromo-4-oxopentanoate)
• 75487-14-8(Hexanoic acid, 3,5-dibromo-4-oxo-, ethyl ester)
• 148728-48-7(Dimethyl 3-bromo-2-oxopentanedioate)
• 57332-84-0(Ethyl a-Bromoethylglyoxalate)
• 34329-73-2(methyl 3-bromo-2-oxo-butanoate)
• 18903-16-7(Butanedioic acid, bromooxo-, diethyl ester)
• 854431-72-4(2,3-Furandione,4-bromodihydro-)
• 61964-76-9(Butanoic acid, 3-bromo-2-oxo-, 1,1-dimethylethyl ester)
• 88260-32-6(Octanoic acid, 3,8-dibromo-2-oxo-, ethyl ester)